-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Apomorphine hydrochloride hemihydrate is a pharmaceutical compound commonly used in the treatment of Parkinson's disease, a neurological disorder that affects movement and balance.
The production process of apomorphine hydrochloride hemihydrate involves several steps, including synthesis, purification, and formulation.
Step 1: Synthesis of Apomorphine
The synthesis of apomorphine involves several chemical reactions, starting with the reaction of morphone with hydrochloric acid to form morphone hydrochloride.
The reaction is carried out in a suitable solvent, such as water or ethanol, and the resulting morphone hydrochloride is isolated by filtration and washing with water.
Next, the morphone hydrochloride is treated with an alkaline solution, such as sodium hydroxide, to form morhapsimide.
The reaction is carried out in a suitable solvent, such as water or ethanol, and the resulting morhapsimide is isolated by filtration and washing with water.
Finally, the morhapsimide is treated with chloroform and a suitable base, such as sodium hydroxide, to form apomorphine.
The resulting apomorphine is isolated by filtration and washing with water, and the resulting solid is dried under vacuum.
Step 2: Purification of Apomorphine
The purification of apomorphine involves several steps, including crystallization, filtration, and recrystallization.
The crude apomorphine obtained from the synthesis step is dissolved in a suitable solvent, such as chloroform or ethanol, and the resulting solution is filtered to remove any impurities.
The filtered solution is then subjected to recrystallization, in which the solvent is slowly evaporated, and the resulting crystals are collected and dried under vacuum.
The resulting apomorphine crystals are washed with a suitable solvent, such as ethanol, and dried again under vacuum.
Step 3: Formulation of Apomorphine Hydrochloride Hemihydrate
The formulation of apomorphine hydrochloride hemihydrate involves mixing the purified apomorphine with a suitable excipient, such as mannitol or lactose.
The resulting mixture is then subjected to granulation, in which the mixture is mixed with a suitable granulating agent, such as starch or povidone, to form small granules.
The granules are then dried and mixed with a suitable lubricant, such as magnesium stearate, and the resulting mixture is compressed into tablets using a suitable tableting machine.
The tablets are then coated with a suitable coating agent, such as hydroxypropyl methylcellulose, to protect the apomorphine from degradation and to improve its stability.
Quality Control of Apomorphine Hydrochloride Hemihydrate
To ensure the quality and efficacy of apomorphine hydrochloride hemihydrate, several tests are performed, including:
- Chemical Tests: These tests include determination of the chemical composition, including the presence of impurities, and the assay of the active ingredient.
- Microbiological Tests: These tests include the determination of the presence of microorganisms, such as bacteria and fungi, and the assessment of the stability of the product.
- Physical Tests: These tests include determination of the physical characteristics of the product, including the size, shape, and density of the tablets, and the assessment of the drug release pattern.
- Non-uniformity Test: The non-uniformity test is used to ensure that the drug substance, excipients and the mixture of both are well mixed and no heterogeneity exists in the final product.
Conclusion
In conclusion, the production process of apomorphine hydrochloride hemihydrate involves several steps